Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
Streptomyces have been presented as a great source of antibiotics and anti-cancer drugs over the past century. Especially Streptomyces living in adverse conditions produce certain metabolites with cytolytic and anti-microbial activities, which have been utilised for manufacturing antimicrobial and a...
Saved in:
Main Authors: | Kaur Prabhjot, Bhandari Divya Dhawal, Chopra Hitesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2024-01-01
|
Series: | Scripta Medica |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2024/2490-33292406775K.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01) -
Biogenic synthesis of titanium nanoparticles by Streptomyces rubrolavendulae for sustainable management of Icerya aegyptiaca (Douglas)
by: Enayat M. Elqady, et al.
Published: (2025-01-01) -
Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01) -
The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
by: Saba Dadpour, et al.
Published: (2022-09-01) -
Investigating novel Streptomyces bacteriophage endolysins as potential antimicrobial agents
by: Jindanuch Maneekul, et al.
Published: (2025-01-01)